| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
Divisions of 1 Cancer Genomics and Proteomics, 2 Signaling Biology, and 3 Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital; Departments of 4 Medical Biophysics and 5 Laboratory Medicine and Pathobiology, 6 Computer Science, University of Toronto, Canada; and 7 Fred Litwin Cancer Genetics Center, Samuel Lunenfeld Research Institute Mount Sinai Hospital, Toronto, Ontario, Canada
Requests for reprints: Linda Z. Penn, Division of Cancer Genomics and Proteomics, Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, Toronto, Canada M5G 2M9. Phone: 416-946-2276; Fax: 416-946-2840; E-mail: lpenn{at}uhnres.utoronto.ca.
The product of the MYC oncogene is widely deregulated in cancer and functions as a regulator of gene transcription. Despite an extensive profile of regulated genes, the transcriptional targets of c-Myc essential for transformation remain unclear. In this study, we show that c-Myc significantly induces the expression of the H19 noncoding RNA in diverse cell types, including breast epithelial, glioblastoma, and fibroblast cells. c-Myc binds to evolutionarily conserved E-boxes near the imprinting control region to facilitate histone acetylation and transcriptional initiation of the H19 promoter. In addition, c-Myc down-regulates the expression of insulin-like growth factor 2 (IGF2), the reciprocally imprinted gene at the H19/IGF2 locus. We show that c-Myc regulates these two genes independently and does not affect H19 imprinting. Indeed, allele-specific chromatin immunoprecipitation and expression analyses indicate that c-Myc binds and drives the expression of only the maternal H19 allele. The role of H19 in transformation is addressed using a knockdown approach and shows that down-regulation of H19 significantly decreases breast and lung cancer cell clonogenicity and anchorage-independent growth. In addition, c-Myc and H19 expression shows strong association in primary breast and lung carcinomas. This work indicates that c-Myc induction of the H19 gene product holds an important role in transformation. (Cancer Res 2006; 66(10): 5330-7)
This article has been cited by other articles:
![]() |
P. C. Boutros, S. K. Lau, M. Pintilie, N. Liu, F. A. Shepherd, S. D. Der, M.-S. Tsao, L. Z. Penn, and I. Jurisica Prognostic gene signatures for non-small-cell lung cancer PNAS, February 24, 2009; 106(8): 2824 - 2828. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aviel-Ronen, B. P. Coe, S. K. Lau, G. da Cunha Santos, C.-Q. Zhu, D. Strumpf, I. Jurisica, W. L. Lam, and M.-S. Tsao Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features PNAS, July 22, 2008; 105(29): 10155 - 10160. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Lau, P. C. Boutros, M. Pintilie, F. H. Blackhall, C.-Q. Zhu, D. Strumpf, M. R. Johnston, G. Darling, S. Keshavjee, T. K. Waddell, et al. Three-Gene Prognostic Classifier for Early-Stage Non Small-Cell Lung Cancer J. Clin. Oncol., December 10, 2007; 25(35): 5562 - 5569. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Kim, M. Shago, L. Kaustov, P. C. Boutros, J. W. Clendening, Y. Sheng, G. A. Trentin, D. Barsyte-Lovejoy, D. Y.L. Mao, R. Kay, et al. CUL7 Is a Novel Antiapoptotic Oncogene Cancer Res., October 15, 2007; 67(20): 9616 - 9622. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Q. Zhu, S. N. Popova, E. R. S. Brown, D. Barsyte-Lovejoy, R. Navab, W. Shih, M. Li, M. Lu, I. Jurisica, L. Z. Penn, et al. Integrin {alpha}11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells PNAS, July 10, 2007; 104(28): 11754 - 11759. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Mattick A new paradigm for developmental biology J. Exp. Biol., May 1, 2007; 210(9): 1526 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Prasanth and D. L. Spector Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum Genes & Dev., January 1, 2007; 21(1): 11 - 42. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |